How Chlamydia bacteria control their survival inside human cells
Official title: Regulation of homotypic fusion by Chlamydia
Funded at Thomas Jefferson University · NIH-11030811 · Data updated 2026-11-12
This study is looking at how the Chlamydia bacteria, which can cause infections and even blindness, manage to live and grow inside our cells, focusing on a special protein that helps them do this, with the hope of finding better ways to prevent and treat these infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | February 7, 2024 |
| Project end | December 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $533,307 |
| NIH project number | 5R01AI181264-02 |
| Project ID | NIH-11030811 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Chlamydia trachomatis infections, particularly those experiencing severe symptoms or complications.
✕Less likely to help
Patients who are not infected with Chlamydia or those with other unrelated health conditions may not benefit from this research.
What this research studies
This research investigates how the bacterium Chlamydia trachomatis, a leading cause of sexually transmitted infections and infectious blindness, survives and replicates within human cells. The focus is on understanding the role of a specific protein, IncA, which is crucial for the fusion of compartments where the bacteria live. By exploring the mechanisms that regulate this fusion, the research aims to uncover new insights into Chlamydia's pathogenicity and its interaction with host cells. This could lead to better strategies for preventing and treating infections caused by this neglected pathogen.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for Chlamydia infections, potentially reducing the incidence of related diseases.
How similar studies have gone: While research on Chlamydia has been ongoing, the specific focus on the regulatory mechanisms of homotypic fusion is relatively novel and has not been extensively tested.
Where this research is happening
-
Thomas Jefferson University
Philadelphia, United States Active
Researchers
- Principal investigator: Paumet, Fabienne Michelle — Thomas Jefferson University
- Study coordinator: Paumet, Fabienne Michelle
Related research
Other NIH-funded projects on the same topics.
-
Understanding CAG repeat instability in Huntington’s disease
A Huntington’s disease study explores why the CAG repeat in the HTT gene becomes unstable and leads to earlier disease, aiming to uncover factors that influence when and how the disease starts.
-
Noninvasive portal pressure estimation using ultrasound-based subharmonic signals
A noninvasive ultrasound method to estimate portal vein pressure in adults with cirrhosis to help manage varices and ascites.
-
Twice-reading RNA sequencing to better map RNA modifications
Researchers are using a novel method to read RNA twice to more accurately map chemical modifications in human transcripts, which could help us understand health and disease.
-
Improving HIV Prevention for Women in ObGyn Care
Aimed at helping women in obstetric/gynecologic care reduce their risk of HIV by making PrEP and risk–screening more accessible and acceptable.
-
Immunostimulatory short non-coding RNAs and lupus
A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.
-
Global Network for Women’s and Children’s Health: New Cycle Leadership and Collaboration
A long-standing collaboration between TJU and JNMC is expanding to lead and coordinate efforts to improve the health of mothers and young children in low-resource settings.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.